27
Mar 2026
FDA approves first gene therapy for rare pediatric immune disorder
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.
Stay Informed!
27
Mar 2026
Industry and academic leaders gather to accelerate new cancer cures
Damon Runyon scientists and industry partners gathered on Tuesday, March 24, for the 2026 Accelerating Cancer Cures Research Symposium, hosted by Amgen in Cambridge, Massachusetts.
27
Mar 2026
New AI system maps gene expression across the whole body
Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these technologies only focus on one organ or one small area of tissue.
27
Mar 2026
Mount Sinai team wins million dollar prize for the development of Biomni-AD
A team led by Dr. Kuan-lin Huang, PhD, has been named a winner of the $1 million Alzheimer's Insights AI Prize, the Alzheimer's Disease Data Initiative (AD Data Initiative) announced on March 20. Dr. Huang is an Associate Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai.
27
Mar 2026
TENS therapy reduces movement pain and fatigue in fibromyalgia patients
Adding TENS (transcutaneous electrical nerve stimulation) to outpatient physical therapy reduced movement-based pain and fatigue in patients with fibromyalgia, and the effects lasted for at least six months, according to a new study led by researchers at University of Iowa Health Care.
27
Mar 2026
Advanced endoscopic technique successfully treats early-stage colorectal cancer
In the months before his wedding, Queens resident Roberto Pineda Sanchez noticed persistent rectal bleeding, a dangerous symptom he almost ignored.
27
Mar 2026
Ticks can survive for up to three weeks inside homes
It's fairly common for members of the public to ask bug experts if ticks that hitchhike into a house on people or dogs can actually survive indoors for any length of time.
27
Mar 2026
Guselkumab shows minor added benefit for specific Crohn's disease patients
The human monoclonal antibody guselkumab has been approved for certain adults with moderately to severely active ulcerative colitis since April 2025.
27
Mar 2026
LDCT screening significantly reduces lung cancer mortality in non-smokers
New evidence from a Chinese cohort presented today at the European Lung Cancer Congress (ELCC) 2026 shows that onetime lowdose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non-risk based population, including individuals with no smoking history.
27
Mar 2026
New AI tool assesses the potential threat posed by new bacteria
Researchers have developed an AI tool that can help determine whether unfamiliar bacteria carry genetic features linked to disease.
